Patients with aortic stenosis referred for TAVI : Treatment decision, in-hospital outcome and determinants of survival

Aims To assess treatment decision and outcome in patients referred for transcatheter aortic valve implantation (TAVI) in addition to predictive factors of mortality after TAVI. Methods Three-centre prospective observational study including 358 patients. Endpoints were defined according to the Valve...

Full description

Autores:
Tipo de recurso:
Fecha de publicación:
2012
Institución:
Universidad del Rosario
Repositorio:
Repositorio EdocUR - U. Rosario
Idioma:
eng
OAI Identifier:
oai:repository.urosario.edu.co:10336/21871
Acceso en línea:
https://doi.org/10.1007/s12471-011-0224-z
https://repository.urosario.edu.co/handle/10336/21871
Palabra clave:
Promoción de salud
Enfermedades
Aortic stenosis
Transcatheter aortic valve implantation
Surgical aortic valve replacement
Treatment decision
Complications
Prognosis
Rights
License
Abierto (Texto Completo)
id EDOCUR2_173095a0557cfaff50f832204705828c
oai_identifier_str oai:repository.urosario.edu.co:10336/21871
network_acronym_str EDOCUR2
network_name_str Repositorio EdocUR - U. Rosario
repository_id_str
dc.title.spa.fl_str_mv Patients with aortic stenosis referred for TAVI : Treatment decision, in-hospital outcome and determinants of survival
title Patients with aortic stenosis referred for TAVI : Treatment decision, in-hospital outcome and determinants of survival
spellingShingle Patients with aortic stenosis referred for TAVI : Treatment decision, in-hospital outcome and determinants of survival
Promoción de salud
Enfermedades
Aortic stenosis
Transcatheter aortic valve implantation
Surgical aortic valve replacement
Treatment decision
Complications
Prognosis
title_short Patients with aortic stenosis referred for TAVI : Treatment decision, in-hospital outcome and determinants of survival
title_full Patients with aortic stenosis referred for TAVI : Treatment decision, in-hospital outcome and determinants of survival
title_fullStr Patients with aortic stenosis referred for TAVI : Treatment decision, in-hospital outcome and determinants of survival
title_full_unstemmed Patients with aortic stenosis referred for TAVI : Treatment decision, in-hospital outcome and determinants of survival
title_sort Patients with aortic stenosis referred for TAVI : Treatment decision, in-hospital outcome and determinants of survival
dc.subject.ddc.spa.fl_str_mv Promoción de salud
Enfermedades
topic Promoción de salud
Enfermedades
Aortic stenosis
Transcatheter aortic valve implantation
Surgical aortic valve replacement
Treatment decision
Complications
Prognosis
dc.subject.keyword.spa.fl_str_mv Aortic stenosis
Transcatheter aortic valve implantation
Surgical aortic valve replacement
Treatment decision
Complications
Prognosis
description Aims To assess treatment decision and outcome in patients referred for transcatheter aortic valve implantation (TAVI) in addition to predictive factors of mortality after TAVI. Methods Three-centre prospective observational study including 358 patients. Endpoints were defined according to the Valve Academic Research Consortium. Results Of the 358 patients referred for TAVI, TAVI was performed in 235 patients (65%), surgical aortic valve replacement (AVR) in 24 (7%) and medical therapy (MT) in 99 (28%). Reasons to decline TAVI in favour of AVR/MT were patient preference (29%), peripheral vascular disease (15%) and non-severe aortic stenosis (11%). The logistic EuroSCORE was significantly higher in patients who underwent TAVI and MT in comparison with those undergoing AVR (19 vs. 10%, p=0.007). At 30 days, all-cause mortality and the combined safety endpoint were 9 and 24% after TAVI and 8 and 25% after AVR, respectively. All-cause mortality was significantly lower in the TAVI group compared with the MT group at 6 months, 1 year and 2 years (12% vs. 22%, 21% vs. 33% and 31% vs. 55%, respectively, p<0.001). Multivariable analysis revealed that blood transfusion (HR: 1.19; 95% CI: 1.05-1.33), pre-existing renal failure (HR: 1.18; 95% CI: 1.06-1.33) and STS score (HR: 1.06; 95% CI: 1.02-1.10) were independent predictors of mortality at a median of 10 (IQR: 3-23) months after TAVI. Conclusions Approximately two-thirds of the patients referred for TAVI receive this treatment with gratifying short- and long-term survival. Another 7% underwent AVR. Prognosis is poor in patients who do not receive valve replacement therapy. © The Author(s) 2011.
publishDate 2012
dc.date.created.none.fl_str_mv 2012
dc.date.issued.none.fl_str_mv 2012
dc.date.accessioned.none.fl_str_mv 2020-05-05T23:23:16Z
dc.date.available.none.fl_str_mv 2020-05-05T23:23:16Z
dc.type.eng.fl_str_mv article
dc.type.coarversion.fl_str_mv http://purl.org/coar/version/c_970fb48d4fbd8a85
dc.type.coar.fl_str_mv http://purl.org/coar/resource_type/c_6501
dc.type.spa.spa.fl_str_mv Artículo
dc.identifier.doi.none.fl_str_mv https://doi.org/10.1007/s12471-011-0224-z
dc.identifier.issn.none.fl_str_mv 1568-5888
dc.identifier.uri.none.fl_str_mv https://repository.urosario.edu.co/handle/10336/21871
url https://doi.org/10.1007/s12471-011-0224-z
https://repository.urosario.edu.co/handle/10336/21871
identifier_str_mv 1568-5888
dc.language.iso.spa.fl_str_mv eng
language eng
dc.relation.citationEndPage.none.fl_str_mv 23
dc.relation.citationIssue.none.fl_str_mv No. 1
dc.relation.citationStartPage.none.fl_str_mv 16
dc.relation.citationTitle.none.fl_str_mv Netherlands Heart Journal
dc.relation.citationVolume.none.fl_str_mv Vol. 20
dc.relation.ispartof.spa.fl_str_mv Netherlands Heart Journal, ISSN: 1568-5888 Vol. 20, No. 1 (2012) pp. 16-23
dc.relation.uri.spa.fl_str_mv https://link.springer.com/content/pdf/10.1007%2Fs12471-011-0224-z.pdf
dc.rights.coar.fl_str_mv http://purl.org/coar/access_right/c_abf2
dc.rights.acceso.spa.fl_str_mv Abierto (Texto Completo)
rights_invalid_str_mv Abierto (Texto Completo)
http://purl.org/coar/access_right/c_abf2
dc.format.mimetype.none.fl_str_mv application/pdf
institution Universidad del Rosario
dc.source.instname.none.fl_str_mv instname:Universidad del Rosario
dc.source.reponame.none.fl_str_mv reponame:Repositorio Institucional EdocUR
bitstream.url.fl_str_mv https://repository.urosario.edu.co/bitstreams/e0b44812-e52e-4ec6-977a-1d6c7ae2b025/download
https://repository.urosario.edu.co/bitstreams/2e396eb7-79c4-4031-9a32-d7f187d6b90b/download
https://repository.urosario.edu.co/bitstreams/69830887-31d1-498a-85a9-010bed6cf874/download
bitstream.checksum.fl_str_mv 8e6a708549d31afa4e4bb84fe4613275
30024f9353725fa0e0dafc5f7154c3ee
fdb2e06f72ab45ba67535269ce9ecf59
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
repository.name.fl_str_mv Repositorio institucional EdocUR
repository.mail.fl_str_mv edocur@urosario.edu.co
_version_ 1814167659119378432
spelling 9b8e1aeb-fa42-44f8-ab35-723d3f4f78bf-18cd9a000-2454-4448-b704-490b681e5ed2-1b1f7fbd8-0182-416e-a574-bbf27625764c-13afe603d-fcf1-4613-b039-2f0890796472-1dba6e67b-6bfd-4d66-b9d5-9abd825e744a-1b9080818-6724-4bd2-85cc-01548051db0b-181fcb6d3-f076-4c8f-9ac1-8bafe6f76b25-11a019a60-a808-4f33-887b-43d109da4f47-1ef596336-4bbd-4dd0-b401-c365079c050a-109e4fc58-75f0-490b-897b-b941449c1eee-19a7bc159-2032-44b8-9c6b-276d40bb3ed4-11435df54-e507-4802-a066-3ffd57279725-12020-05-05T23:23:16Z2020-05-05T23:23:16Z20122012Aims To assess treatment decision and outcome in patients referred for transcatheter aortic valve implantation (TAVI) in addition to predictive factors of mortality after TAVI. Methods Three-centre prospective observational study including 358 patients. Endpoints were defined according to the Valve Academic Research Consortium. Results Of the 358 patients referred for TAVI, TAVI was performed in 235 patients (65%), surgical aortic valve replacement (AVR) in 24 (7%) and medical therapy (MT) in 99 (28%). Reasons to decline TAVI in favour of AVR/MT were patient preference (29%), peripheral vascular disease (15%) and non-severe aortic stenosis (11%). The logistic EuroSCORE was significantly higher in patients who underwent TAVI and MT in comparison with those undergoing AVR (19 vs. 10%, p=0.007). At 30 days, all-cause mortality and the combined safety endpoint were 9 and 24% after TAVI and 8 and 25% after AVR, respectively. All-cause mortality was significantly lower in the TAVI group compared with the MT group at 6 months, 1 year and 2 years (12% vs. 22%, 21% vs. 33% and 31% vs. 55%, respectively, p<0.001). Multivariable analysis revealed that blood transfusion (HR: 1.19; 95% CI: 1.05-1.33), pre-existing renal failure (HR: 1.18; 95% CI: 1.06-1.33) and STS score (HR: 1.06; 95% CI: 1.02-1.10) were independent predictors of mortality at a median of 10 (IQR: 3-23) months after TAVI. Conclusions Approximately two-thirds of the patients referred for TAVI receive this treatment with gratifying short- and long-term survival. Another 7% underwent AVR. Prognosis is poor in patients who do not receive valve replacement therapy. © The Author(s) 2011.application/pdfhttps://doi.org/10.1007/s12471-011-0224-z1568-5888https://repository.urosario.edu.co/handle/10336/21871eng23No. 116Netherlands Heart JournalVol. 20Netherlands Heart Journal, ISSN: 1568-5888 Vol. 20, No. 1 (2012) pp. 16-23https://link.springer.com/content/pdf/10.1007%2Fs12471-011-0224-z.pdfAbierto (Texto Completo)http://purl.org/coar/access_right/c_abf2instname:Universidad del Rosarioreponame:Repositorio Institucional EdocURPromoción de salud613600Enfermedades616600Aortic stenosisTranscatheter aortic valve implantationSurgical aortic valve replacementTreatment decisionComplicationsPrognosisPatients with aortic stenosis referred for TAVI : Treatment decision, in-hospital outcome and determinants of survivalarticleArtículohttp://purl.org/coar/version/c_970fb48d4fbd8a85http://purl.org/coar/resource_type/c_6501Nuis, R.J.Dager, A.E.Van der Boon, R.M.Jaimes, M.C.Caicedo, B.Fonseca, J.Van Mieghem, N.M.Benitez, L.M.Umana, J.P.O'Neill, W.W.de Marchena, E.de Jaegere, P.P.Nuis, R.J.Dager, A.E.Van der Boon, R.M.Jaimes, M.C.Caicedo, B.Fonseca, J.Van Mieghem, N.M.Benitez, L.M.Umana, J.P.O'Neill, W.W.de Marchena, E.de Jaegere, P.P.ORIGINALPatients_with_aortic_stenosis_referred_for_TAVI.pdfapplication/pdf241720https://repository.urosario.edu.co/bitstreams/e0b44812-e52e-4ec6-977a-1d6c7ae2b025/download8e6a708549d31afa4e4bb84fe4613275MD51TEXTPatients_with_aortic_stenosis_referred_for_TAVI.pdf.txtPatients_with_aortic_stenosis_referred_for_TAVI.pdf.txtExtracted texttext/plain29790https://repository.urosario.edu.co/bitstreams/2e396eb7-79c4-4031-9a32-d7f187d6b90b/download30024f9353725fa0e0dafc5f7154c3eeMD52THUMBNAILPatients_with_aortic_stenosis_referred_for_TAVI.pdf.jpgPatients_with_aortic_stenosis_referred_for_TAVI.pdf.jpgGenerated Thumbnailimage/jpeg4533https://repository.urosario.edu.co/bitstreams/69830887-31d1-498a-85a9-010bed6cf874/downloadfdb2e06f72ab45ba67535269ce9ecf59MD5310336/21871oai:repository.urosario.edu.co:10336/218712021-06-03 00:49:20.598https://repository.urosario.edu.coRepositorio institucional EdocURedocur@urosario.edu.co